Table 1.
Baseline, discharge, and 12-months post-discharge scores across patient-reported outcome measures
| Measure | Subscale | Cutoffs/norms | Baseline | Discharge | 12-Months post-discharge | Δ During treatment | Δ 12-Months post-discharge |
|---|---|---|---|---|---|---|---|
| EDE-Q | 3.89 (1.04) | 3.88a | 1.44 | 0.94 | − 2.44b | − 0.50 | |
| Restraint | 2.43 (1.67) | 3.60a | 0.20 | 0.40 | − 3.40 | + 0.20 | |
| Eating Concern | 3.45 (1.34) | 3.40a | 0.40 | 0.20 | − 3.00 | − 0.20 | |
| Shape Concern | 4.91 (1.15) | 4.50a | 2.75 | 1.75 | − 1.75 | − 1.00 | |
| Weight Concern | 4.18 (1.12) | 4.00a | 2.40 | 1.40 | − 1.60 | − 1.00 | |
| EDQOL | 1.29 (0.54) | 1.64a | 0.32 | 0.28 | − 1.32 | − 0.04 | |
| Psychological | 2.20 (0.89) | 2.78a | 0.89 | 0.56 | − 1.89 | − 0.33 | |
| Physical/Cognitive | 1.52 (0.76) | 1.83a | 0.00 | 0.33 | − 1.83 | 0.33 | |
| Financial | 0.38 (0.69) | 0.80a | 0.00 | 0.00 | − 0.80 | None | |
| Work/School | 0.24 (0.54) | 0.20a | 0.00 | 0.00 | − 0.20 | None | |
| IES-2 | 2.18 (0.42) | 1.91a | 3.57 | 3.61 | + 1.66 | + 0.04 | |
| UPE | 2.87 (0.75) | 2.50a | 4.50 | 4.00 | + 2.00 | − 0.50 | |
| EPR | 1.68 (0.68) | 1.25a | 3.63 | 4.00 | + 2.38 | + 0.27 | |
| RHSC | 1.88 (0.67) | 2.17a | 3.17 | 3.67 | + 1.00 | + 0.50 | |
| BFCC | 2.51 (0.93) | 2.00a | 2.33a | 1.67a | + 0.33 | − 0.66 | |
| PHQ-9 | 4 | 19a | 5a | 4 | − 14b | − 1 | |
| STAI-S | 40 | 39 | 21 | 21 | − 18b | None | |
| STAI-T | 40 | 61a | 33 | 36 | − 28b | + 3 | |
EDE-Q Eating Disorder Examination Questionnaire, EDQOL Eating Disorder Quality of Life Questionnaire, IES-2 Intuitive Eating Scale, UPE Unconditional Permission to Eat subscale, EPR Eating for Physical Reasons subscale, RHSC Reliance on Hunger and Satiety Cues subscale, BFCC Body-Food Choice Congruence, PHQ-9 Patient Health Questionnaire, STAI-S State Trait Anxiety Inventory-State, STAI-T State Trait Anxiety Inventory-Trait
aScore was in clinical range based on reported clinical cutoff and norm values
bMagnitude of change in patient’s scores from baseline to discharge represents a clinically significant treatment response